See other bills
under the
same topic
                                                      PRINTER'S NO. 1116

THE GENERAL ASSEMBLY OF PENNSYLVANIA


HOUSE BILL

No. 950 Session of 2007


        INTRODUCED BY RAPP, SONNEY, CURRY, WATSON, YOUNGBLOOD, BAKER,
           CAPPELLI, CLYMER, COHEN, CREIGHTON, EVERETT, FABRIZIO, GEIST,
           GEORGE, GINGRICH, HARHAI, HENNESSEY, HORNAMAN, JAMES,
           JOSEPHS, M. KELLER, KIRKLAND, KORTZ, KOTIK, KULA, LEACH,
           McILHATTAN, MILLARD, NAILOR, PHILLIPS, PICKETT, RUBLEY,
           SANTONI, SAYLOR, SCHRODER, McILVAINE SMITH, SOLOBAY, THOMAS
           AND VULAKOVICH, MARCH 29, 2007

        REFERRED TO COMMITTEE ON HEALTH AND HUMAN SERVICES,
           MARCH 29, 2007

                                     AN ACT

     1  Amending the act of September 9, 1965 (P.L.497, No.251),
     2     entitled "An act requiring physicians, hospitals and other
     3     institutions to administer or cause to be administered tests
     4     for phenylketonuria and other metabolic diseases upon infants
     5     in certain cases," further providing for newborn child
     6     screening and testing.

     7     The General Assembly of the Commonwealth of Pennsylvania
     8  hereby enacts as follows:
     9     Section 1.  Section 3 of the act of September 9, 1965
    10  (P.L.497, No.251), known as the Newborn Child Testing Act, added
    11  July 9, 1992 (P.L.398, No.86), is amended to read:
    12     Section 3.  Newborn Child Screening and Follow-up Program.--
    13  (a)  In order to assist health care providers to determine
    14  whether treatment or other services are necessary to avert
    15  mental retardation, permanent disabilities or death, the
    16  department, with the approval of the board, shall establish a
    17  program providing for:

     1     (1)  The screening tests of newborn children for diseases.
     2     (2)  Follow-up services relating to confirmatory testing,
     3  assessment and diagnosis of newborn children with abnormal or
     4  inconclusive screening test results.
     5     (b)  The department, with the approval of the board, shall
     6  establish by regulation those diseases, in addition to
     7  phenylketonuria (PKU), maple syrup urine disease (MSUD) [and],
     8  sickle-cell disease (hemoglobinopathies) and retinoblastoma, for
     9  which newborn children shall be tested and the methods for
    10  testing and disseminating test results.
    11     (c)  No screening test shall be performed if a parent or
    12  guardian dissents on the ground that the test conflicts with a
    13  religious belief or practice.
    14     Section 2.  This act shall take effect in 60 days.











    C1L35DMS/20070H0950B1116         - 2 -